{
  "trial_id": "NCT00489385",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age greater than or equal to 18 years.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Documentation of HIV-1 infection by licensed ELISA test and confirmed by a Western Blot.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Documentation of hepatitis C infection by demonstration of a positive test for hepatitis C antibody and HCV RNA level of 2000 copies/mL or greater.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Histopathologic features consistent with chronic hepatitis C at the time of enrollment. A liver biopsy done for a subject within 24 months prior to his or her participation may be used as the baseline biopsy.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients infected with genotype 1.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with CD4+ cell counts greater than 100 cells/mm(3).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Ability to sign the Informed Consent document, and willingness to comply with the study requirements and clinic policies.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Neutrophil count greater than 1000 cells/mm(3).",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Platelets greater than 75,000/mm(3).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hemoglobin greater than 10.5 g/dL.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "ALT less than 7 times the NIH upper limit of normal.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Serum lipase less than 1.5 times the NIH upper limit of normal.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Not pregnant or breast-feeding.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patient cannot be on other experimental therapies (including expanded access/compassionate use of antiretrovirals) during his/her participation in this protocol.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients cannot have used interferon or peginterferon previously for the treatment of hepatitis C.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Mixed genotypes (e.g., 1/2, 1/4). Mixed genotype 1a/1b will be enrolled.",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 53-year-old man with chronic HCV infection. He has been on IFN and RBV combination therapy for the past 9 months, with direct antiviral drugs added 6 months ago.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT00489385",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}